Dror Ortho-Design, Inc. (ticker: DROR) is an OTC-listed clinical biotech company. DredgeCap's structured extraction of DROR's SEC filings surfaces 16 active risk signals, including 14 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. DROR reported $3K in revenue and -$639K for the period ending 2021-12-31, with operating cash flow of -$404K. Cash and equivalents stood at $24K (down 93.2% year-over-year). Total assets of $254K are exceeded by total liabilities of $3.57M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
DROR Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Dror Ortho-Design, Inc. (DROR) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.